Contralateral Axillary Lymph Node Metastases from Breast Carcinoma: Is it Time to Review TNM Cancer Staging?
Francesca MagnoniM ColleoniD MattarG CorsoV BagnardiS FrassoniG SantomauroB A Jereczek-FossaP VeronesiV GalimbertiV SacchiniM IntraPublished in: Annals of surgical oncology (2020)
These findings, together with those from previous studies, show that CAM outcome, particularly if measured as OS, appear better than at other sites of distant dissemination, when CAM is subjected to surgical and systemic treatments with a curative intent. Therefore, a new clinical scenario is suggested where, in the TNM system, CAM is no longer classified as a stage IV, but as an N3 disease.